Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study

por Đekić, Danijel, Bojić, Mirjana, Janež, Andrej, Klobučar, Sanja, Hadžimušović, Iris Grčić, Ković, Tijana, Mihalevska, Svetla
Publicado 2023

Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observatio...

por Velojic-Golubovic, Milena, Ciric, Vojislav, Dimitrijevic, Marija, Kovic, Tijana, Mitic, Milica, Olujic, Biljana, Pevac, Natasa, Radenkovic, Sasa, Radojkovic, Danijela, Vukadinovic, Selena, Popovic, Djordje S.
Publicado 2021